July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Femtosecond laser assisted cataract surgery combined with intravitreal dexamethasone implant in patients with cataract and diabetic macular edema
Author Affiliations & Notes
  • Claudio Furino
    UO Oftalmologia Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy
  • Maria Oliva Grassi
    UO Oftalmologia Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy
  • Alfredo Niro
    UO Oftalmologia Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy
  • Francesco Boscia
    Dep of Ophthalmology, University of Sassari, Sassari, Italy
  • Nicola Recchimurzo
    UO Oftalmologia Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy
  • Carmela Palmisano
    UO Oftalmologia Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy
  • Alfonso Montepara
    UO Oftalmologia Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy
  • Giovanni Alessio
    UO Oftalmologia Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy
  • Footnotes
    Commercial Relationships   Claudio Furino, None; Maria Oliva Grassi, None; Alfredo Niro, None; Francesco Boscia, None; Nicola Recchimurzo, None; Carmela Palmisano, None; Alfonso Montepara, None; Giovanni Alessio, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4846. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Claudio Furino, Maria Oliva Grassi, Alfredo Niro, Francesco Boscia, Nicola Recchimurzo, Carmela Palmisano, Alfonso Montepara, Giovanni Alessio; Femtosecond laser assisted cataract surgery combined with intravitreal dexamethasone implant in patients with cataract and diabetic macular edema. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4846.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the effectiveness and safety of combined femtosecond laser assisted cataract surgery and dexamethasone intravitreal implant in patients with coexisting cataract and diabetic macular edema (DME).

Methods : The charts of 14 (6 female, 8 male) consecutive patients who underwent combined femtosecond laser assisted phacoemulsification and intravitreal dexamethasone implant were retrospectively reviewed. All the patients observed 3 months of follow-up. Primary outcome was the change of the central retinal thickness (CRT); secondary outcome was the change of best-corrected visual acuity (BCVA). Any ocular complications were recorded.

Results : Mean CRT decreased significantly from 410±93 microns at baseline to 325±30 microns at 30 days (p = .003), to 305±30 microns at 60 days (p = .0005), and to 335±58 microns at 90 days (p = .016). Mean BCVA was 20/115 (logMAR, 0.75±0.36) at baseline and improved significantly to 20/55 (p =.018) at 30 days, to 20/55 (p=.04) at 60 days and to 20/58 (p=.04) at all postsurgery time points. No case of ocular hypertension was observed. No endophthalmitis or other ocular complications were recorded.

Conclusions : Combined femtosecond laser assisted cataract surgery and intravitreal slow-release dexamethasone implant appeared to be an effective approach on functional and tomographic outcomes for patients with coexisting cataract and DME for at least three months after surgery.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×